183 related articles for article (PubMed ID: 30857600)
1. Effects of vasopressin during a pulmonary hypertensive crisis induced by acute hypoxia in a rat model of pulmonary hypertension.
Sugawara Y; Mizuno Y; Oku S; Goto T
Br J Anaesth; 2019 Apr; 122(4):437-447. PubMed ID: 30857600
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic Effects of Phenylephrine, Vasopressin, and Epinephrine in Children With Pulmonary Hypertension: A Pilot Study.
Siehr SL; Feinstein JA; Yang W; Peng LF; Ogawa MT; Ramamoorthy C
Pediatr Crit Care Med; 2016 May; 17(5):428-37. PubMed ID: 27144689
[TBL] [Abstract][Full Text] [Related]
3. Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension.
Christou H; Reslan OM; Mam V; Tanbe AF; Vitali SH; Touma M; Arons E; Mitsialis SA; Kourembanas S; Khalil RA
Am J Physiol Lung Cell Mol Physiol; 2012 May; 302(9):L875-90. PubMed ID: 22287610
[TBL] [Abstract][Full Text] [Related]
4. Role of the gap junctions in the contractile response to agonists in pulmonary artery from two rat models of pulmonary hypertension.
Billaud M; Dahan D; Marthan R; Savineau JP; Guibert C
Respir Res; 2011 Mar; 12(1):30. PubMed ID: 21414209
[TBL] [Abstract][Full Text] [Related]
5. Effect of vasopressin on a porcine model of persistent pulmonary hypertension of the newborn.
Amer R; Elsayed YN; Graham MR; Sikarwar AS; Hinton M; Dakshinamurti S
Pediatr Pulmonol; 2019 Mar; 54(3):319-332. PubMed ID: 30644649
[TBL] [Abstract][Full Text] [Related]
6. Effects of vasopressin on right ventricular function in an experimental model of acute pulmonary hypertension.
Leather HA; Segers P; Berends N; Vandermeersch E; Wouters PF
Crit Care Med; 2002 Nov; 30(11):2548-52. PubMed ID: 12441768
[TBL] [Abstract][Full Text] [Related]
7. Systemic vasoconstriction modulates the responses of pulmonary vasculature and airway to vasoconstrictors in anesthetized rats.
Wang M; Shibamoto T; Kuda Y; Tanida M; Kurata Y
Exp Lung Res; 2015; 41(6):324-34. PubMed ID: 26151368
[TBL] [Abstract][Full Text] [Related]
8. Prolonged inhaled NO attenuates hypoxic, but not monocrotaline-induced, pulmonary vascular remodeling in rats.
Horstman DJ; Frank DU; Rich GF
Anesth Analg; 1998 Jan; 86(1):74-81. PubMed ID: 9428855
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of treprostinil in the SU5416-hypoxia model of severe pulmonary arterial hypertension: haemodynamic benefits are not associated with improvements in arterial remodelling.
Chaudhary KR; Deng Y; Suen CM; Taha M; Petersen TH; Mei SHJ; Stewart DJ
Br J Pharmacol; 2018 Oct; 175(20):3976-3989. PubMed ID: 30098019
[TBL] [Abstract][Full Text] [Related]
10. The effect of phenylephrine and norepinephrine in patients with chronic pulmonary hypertension*.
Kwak YL; Lee CS; Park YH; Hong YW
Anaesthesia; 2002 Jan; 57(1):9-14. PubMed ID: 11843735
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor contributes to hypoxic pulmonary vasoconstriction in rats.
Zhang B; Luo Y; Liu ML; Wang J; Xu DQ; Dong MQ; Liu Y; Xu M; Dong HY; Zhao PT; Gao YQ; Li ZC
Microvasc Res; 2012 Mar; 83(2):205-12. PubMed ID: 22005047
[TBL] [Abstract][Full Text] [Related]
12. Preventive effect of sildenafil on right ventricular function in rats with monocrotaline-induced pulmonary arterial hypertension.
Yoshiyuki R; Tanaka R; Fukushima R; Machida N
Exp Anim; 2016 Jul; 65(3):215-22. PubMed ID: 26876436
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase inhibition and vascular reactivity in a rat model of hyperdynamic sepsis.
Fox GA; Paterson NA; McCormack DG
J Cardiovasc Pharmacol; 1996 Jul; 28(1):30-5. PubMed ID: 8797133
[TBL] [Abstract][Full Text] [Related]
14. Low-dose vasopressin in the treatment of vasodilatory septic shock.
Malay MB; Ashton RC; Landry DW; Townsend RN
J Trauma; 1999 Oct; 47(4):699-703; discussion 703-5. PubMed ID: 10528604
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy improves vascular volume in female rats with pulmonary hypertension.
Lachant DJ; Meoli DF; Haight D; Staicu S; Akers S; Glickman S; Ambrosini R; Champion HC; White RJ
Am J Physiol Lung Cell Mol Physiol; 2019 Oct; 317(4):L445-L455. PubMed ID: 31322432
[TBL] [Abstract][Full Text] [Related]
16. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
[TBL] [Abstract][Full Text] [Related]
17. Thrombospondin-1 null mice are resistant to hypoxia-induced pulmonary hypertension.
Ochoa CD; Yu L; Al-Ansari E; Hales CA; Quinn DA
J Cardiothorac Surg; 2010 May; 5():32. PubMed ID: 20441584
[TBL] [Abstract][Full Text] [Related]
18. 17β-estradiol preserves right ventricular function in rats with pulmonary arterial hypertension: an echocardiographic and histochemical study.
Wang YD; Li YD; Ding XY; Wu XP; Li C; Guo DC; Shi YP; Lu XZ
Int J Cardiovasc Imaging; 2019 Mar; 35(3):441-450. PubMed ID: 30350115
[TBL] [Abstract][Full Text] [Related]
19. 3-Hydroxy-3-methylglutaryl (HMG)-COA reductase inhibitors and phosphodiesterase type V inhibitors attenuate right ventricular pressure and remodeling in a rat model of pulmonary hypertension.
Satoh M; Satoh A
J Pharm Pharm Sci; 2009 Feb; 11(2):118s-130s. PubMed ID: 19203474
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of the vasoconstrictor effect of vasopressin in septic shock.
Malay MB; Ashton JL; Dahl K; Savage EB; Burchell SA; Ashton RC; Sciacca RR; Oliver JA; Landry DW
Crit Care Med; 2004 Jun; 32(6):1327-31. PubMed ID: 15187515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
